Cancer Cell

@Cancer_Cell

Cancer Cell provides a high-profile forum for showcasing advances in cancer research, with a strong emphasis on translational research.

Cambridge, MA, USA
Vrijeme pridruživanja: svibanj 2012.

Tweetovi

Blokirali ste korisnika/cu @Cancer_Cell

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Cancer_Cell

  1. Prikvačeni tweet
    13. sij
    Poništi
  2. 31. sij

    Online Now: EZH2 Inhibition Sensitizes CARM1-High, Homologous Recombination Proficient Ovarian Cancers to PARP Inhibition

    Poništi
  3. 30. sij

    Online Now: THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells

    Poništi
  4. 28. sij
    Poništi
  5. 27. sij

    RT Looking forward to this exciting conference. Register soon for discounted delegate fees.

    Poništi
  6. proslijedio/la je Tweet
    24. sij
    Poništi
  7. 25. sij

    An exciting opportunity to join the editorial team at our sister journal

    Poništi
  8. 24. sij

    Online Now: Science that Inspires

    Poništi
  9. proslijedio/la je Tweet
    23. sij

    So proud of Dr. Dhivya Sudhan on the publication of her manuscript in ! Also my first (co) corresponding authorship. Dhivya found that activation of the mTOR pathway drives resistance to in -mutant cancers. Tweetorial below

    Prikaži ovu nit
    Poništi
  10. 24. sij

    Online Now: Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers

    Poništi
  11. 23. sij

    Online Now: Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer

    Poništi
  12. 22. sij

    Scientific Editor Montse Rojo de la Vega is at at Breckenridge, CO. She will be there all week, be sure to catch her to discuss these great talks!

    Poništi
  13. 20. sij

    Senior Editor Harmony Turk is excited for the start of meeting in beautiful Banff.

    Poništi
  14. proslijedio/la je Tweet
    17. sij

    More cool work from the Janne lab figuring out the vulnerabilities of dormant EGFR-mutant NSCLC on TKI. Inhibiting MEK plus YAP/TEAD tips these surviving cells into apoptosis!

    Poništi
  15. proslijedio/la je Tweet
    19. sij

    Recent exciting papers by the place the focus on the epichaperome, the ability to image it and its use as a therapy target in tumors as also has shown in my lab for T-ALL.

    Poništi
  16. 15. sij

    Senesce to Survive: YAP-Mediated Dormancy Escapes EGFR/MEK Inhibition

    Poništi
  17. 15. sij

    Sticking it to KRAS: Covalent Inhibitors Enter the Clinic

    Poništi
  18. 15. sij

    This Is Our Cells Under Pressure: Decreased DNA Damage Repair in Response to Targeted Therapies Facilitates the Emergence of Drug-Resistant Clones

    Poništi
  19. 14. sij

    Cancer Genome Evolutionary Trajectories in Metastasis

    Poništi
  20. 14. sij

    An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates

    Poništi
  21. proslijedio/la je Tweet
    14. sij

    Thanks for visiting to tell us about her unique role as editor and !

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·